Paper
NJC
J = 6.0 Hz, Z-CH2), 1.76 (quint, 2H, J = 6.0 Hz, E-CH2), 2.36 (q, 2H, J = 6.0 Hz, E-CH2-NH), 3.79 (t, 2H, J = 6.0 Hz, Z-CH2-OH),
(s, 3H, E-CH3), 2.44 (s, 3H, Z-CH3), 2.63 (br. s, 4H, E/Z-OH, H2O) 3.85 (t, 2H, J = 6.0 Hz, E-CH2-OH), 5.05 (s, 2H, E-CH2Bn), 5.23
2.97 (t, 2H, J = 5.8 Hz, CH2NH2), 3.44 (br. m, 2H, Z-CH2NH), (s, 2H, Z-CH2Bn), 7.20–7.63 (m, 22H, E/Z-H-Ar), 8.36 (d, 1H,
3.56 (t, 2H, J = 5.8 Hz, E-CH2NH), 3.78–3.89 (m, 6H, J = 5.8 Hz, J = 5.6 Hz, Z-H-6), 8.52 (d, 1H, J = 5.6 Hz, E-H-6), 9.13 (s, 1H,
E/Z-CH2-OH; CH2OH), 7.23–7.66 (m, 20H, E/Z-H-Ar), 8.09 Z-H-8), 9.20 (s, 1H, E-H-8), 10.61 (t, 1H, Z-NH), 10.78 (t, 1H,
(dd, 1H, J = 1.8 Hz, J = 8.1 Hz, Z-H-5), 8.19 (dd, 1H, J = E-NH). 13C NMR (75.47 MHz, CDCl3): d = 32.56, 41.94, 42.08,
1.8 Hz, J = 8.1 Hz, E-H-7), 8.69 (dd, 2H, J = 4.4 Hz, J = 1.8 Hz, 59.75, 104.89, 119.99, 127.43, 127.59, 127.87, 128.41, 128.60,
E/Z-H-6), 10.58 (br. s, 1H, Z-NH), 11.09 (br. s, 1H, E-NH). 128.69, 128.81, 130.25, 130.50, 136.98, 151.19, 166.33, 166.65.
MS-ESI: m/z 438 (M+ + 1). Anal. calcd for C26H23N5O2 + H2O: MS-ESI: m/z 438 (M+ + 1). Anal. calcd for C27H25N5O2 + H2O: C,
C, 68.56; H, 5.53; N, 15.37%. Found: C, 68.93; H, 5.28; N, 69.07; H, 5.80; N, 14.92%. Found: C, 68.77; H, 5.61; N, 14.73%.
14.90%.
(E/Z)-1-(2-Phenylethyl)-3-[(3-hydroxypropylamino)-phenyl-
(E/Z)-1-(4-Ethoxyphenyl)-3-[(3-hydroxypropylamino)-phenyl- methylidene]-1,3-dihydro-2H-pyrido[3,4-b]pyrrolo[3,2-e]pyrazin-
methylidene]-1,3-dihydro-2H-pyrido-[2,3-b]pyrrolo[2,3-e]pyrazin- 2-one 12f. Yellow needles (52 mg, 21%), m.p. 145 1C. E/Z = 2.6 : 1
2-one 6d. Yellow needles (130 mg, 51%), m.p. 208–209 1C. (CDCl3), E/Z = 2.2 : 1 (DMSO-d6). IR (ATR): 3414, 3056, 2944,
E/Z = 7.1 : 1 (CDCl3), E/Z = 2.9 : 1 (DMSO-d6). IR (ATR): 3445, 2826, 2748, 1697, 1609 cmꢂ1 1H NMR (300.13 MHz, CDCl3):
.
3275, 3076, 2978, 2937, 1714, 1642 cmꢂ1. 1H NMR (300.13 MHz, d = 1.87 (quint, 2H, J = 6.0 Hz, Z-CH2), 1.93 (quint, 2H, J =
CDCl3) for crude product 6d: d = 1.37–1.48 (m, 6H, J = 6.0 Hz, 6.0 Hz, E-CH2; 2H, E/Z-OH; H2O), 3.00–3.05 (m, 2H, E-CH2Ph),
E/Z-CH3), 1.85–1.97 (m, 4H, J = 6.0 Hz, E/Z-CH2), 3.46 (q, 2H, 3.12–3.18 (m, 2H, Z-CH2Ph), 3.47 (q, 2H, J = 6.0 Hz, Z-CH2NH),
J = 6.0 Hz, Z-CH2NH), 3.56 (q, 2H, J = 6.0 Hz, E-CH2NH), 3.80 3.51 (q, 2H, J = 6.0 Hz, E-CH2NH), 3.80 (t, 2H, J = 6.0 Hz, Z-CH2-OH),
(t, 2H, J = 5.8 Hz, Z-CH2OH) 3.87 (t, 2H, J = 5.8 Hz, E-CH2OH), 3.87 (t, 2H, J = 6.0 Hz, E-CH2-OH), 4.07–4.12 (m, 2H, E-CH2N),
4.01–4.14 (m, 4H, J = 6.0 Hz, E/Z-CH2O), 6.95 (d, 2H, J = 8.7 Hz, 4.25–4.31 (m, 2H, Z-CH2N), 7.25–7.63 (m, 22 H, E/Z-H-Ar), 8.36
E-H-30/50), 7.07 (d, 2H, J = 8.7 Hz, Z-H-30/50) 7.38–7.65 (m, 20H, (d, 1H, J = 5.6 Hz, Z-H-6), 8.52 (d, 1H, J = 5.6 Hz, E-H-6), 9.13 (s, 1H,
E/Z-H-Ar), 8.09 (dd, 1H, J = 1.9 Hz, J = 8.1 Hz, Z-H-5), 8.18 (dd, Z-H-8), 9.19 (s, 1H, E-H-8), 10.59 (t, 1H, Z-NH), 10.75 (t, 1H, E-NH).
1H, J = 1.8 Hz, J = 8.1 Hz, E-H-7), 8.70 (dd, 1H, J = 4.5 Hz, J = 13C NMR (75.47 MHz, CDCl3): d = 32.31, 32.55, 34.25, 39.81, 42.10,
1.8 Hz, E-H-6), 8.75 (dd, 1H, J = 4.4 Hz, J = 1.9 Hz, Z-H-6), 10.77 59.76, 90.94, 120.00, 126.35, 127.53, 127.92, 128.39, 128.48, 128.82,
(br. s, 1H, Z-NH), 11.06 (br. s, 1H, E-NH). 13C NMR (75.47 MHz, 128.94, 130.46, 138.56, 144.21, 149.14, 151.16, 166.49. MS-ESI: m/z
CDCl3) for crude product 6d: d = 14.77, 32.61, 42.33, 59.25, 452 (M+ + 1). Anal. calcd for C27H25N5O2 + H2O: C, 69.07; H, 5.80; N,
59.50, 63.65, 90.26, 114.75, 115.03, 121.79, 125.57, 127.57, 14.92%. Found: C, 68.77; H, 5.61; N, 14.73%.
128.01, 128.73, 130.25, 130.41, 134.16, 136.81, 147.36, 147.77,
(E/Z)-1-Benzyl-3-[(3-hydroxypropylamino)-phenylmethyli-
148.49, 149.27, 158.11, 166.28, 166.72. MS-ESI: m/z 468 (M+ + 1). dene]-1,3-dihydro-2H-pyrrolo[2,3-b]quinoxaline-7-carboxylic
Anal. calcd for C27H25N5O3: C, 69.36; H, 5.39; N, 14.98%. Found: acid 14e. Yellow needles (111 mg, 42%), m.p. 156 1C. E/Z =
C, 69.13; H, 5.28; N, 14.90%.
(E/Z)-3-[(3-Hydroxypropylamino)-phenylmethylidene]-1,3-
dihydro-2H-1-phenylpyrido[2,3-b]pyrrolo[3,2-e]pyrazin-2-one
2.2 : 1 (DMSO-d6). IR (ATR): 3211, 3058, 3034, 2927, 2878, 1690,
1
1614, 1591, 1573 cmꢂ1. H NMR (300.13 MHz, DMSO-d6): d =
1.71 (quint, 2H, J = 6.3 Hz, Z-CH2), 1.77 (quint, 2H, J = 6.3 Hz,
10a. Yellow needles (175 mg, 75%), m.p. 266 1C. E/Z = 2 : 1 E-CH2), 3.35–3.39 (m, 4H, Z/E-CH2NH), 3.47 (t, 2H, Z-CH2OH),
(CDCl3), E/Z = 1.9 : 1 (DMSO-d6). IR (ATR): 3235, 3059, 2862, 3.58 (t, 2H, E-CH2OH), 4.65 (s, 1H, Z-OH), 4.76 (s, 1H, E-OH),
1711, 1609, 1587, 1561 cmꢂ1 1H NMR (300.13 MHz, CDCl3): 4.93 (s, 2H, E-CH2Bn), 5.15 (s, 2H, Z-CH2Bn), 7.18–7.65 (m, 21H,
.
d = 1.83 (m, 2H, Z-CH2), 1.90 (m, 2H, E-CH2), 2.05 (br. s, 2H, E/Z-H-Ar), 7.84 (dd, 1H, J = 8.5 Hz, J = 1.9 Hz, Z-H-7), 7.95 (d, 1H,
E/Z-OH), 3.43–3.54 (m, 4H, E/Z-CH2NH), 3.77 (t, 2H, J = 5.8 Hz, J = 8.5 Hz, Z-H-8), 8.02 (dd, 1H, J = 8.5 Hz, J = 1.7 Hz, E-H-7), 8.25
Z-CH2OH), 3.83 (t, 2H, J = 5.8 Hz, E-CH2OH), 7.28–7.74 (m, 22H, (d, 1H, J = 1.9 Hz, Z-H-5), 8.31 (d, 1H, J = 1.7 Hz, E-H-5), 10.50
E/Z-H-Ar), 8.16 (dd, 1H, J = 1.7 Hz, J = 8.1 Hz, E-H-5), 8.66 (t, 1H, J = 5.6 Hz, Z-NH), 10.75 (t, 1H, J = 5.6 Hz, E-NH), 13.00
(dd, 1H, J = 1.7 Hz, J = 4.4 Hz, 1H, Z-H-7), 8.74 (dd, 1H, J = (s, 2H, COOH). 13C NMR (75.47 MHz, DMSO-d6): d = 32.31,
1.7 Hz, J = 4.4 Hz, 1H, E-H-7), 10.59 (br. s, 1H, Z-NH), 10.74 32.53, 41.28, 41.43, 42.25, 42.42, 58.27, 58.34, 89.44, 89.72,
(br. s, 1H, E-NH). 13C NMR (75.47 MHz, CDCl3): d = 32.32, 32.62, 125.60, 125.87, 127.30, 127.67, 127.85, 128.06, 128.21, 128.35,
42.01, 59.77, 90.16, 121.58, 126.72, 127.19, 127.63, 128.02, 128.53, 128.60, 129.13, 130.09, 130.21, 130.62, 130.94, 137.10,
128.68, 128.76, 128.99, 130.30, 132.74, 133.90, 135.20, 137.02, 137.33, 137.49, 137.69, 141.39, 142.14, 146.93, 147.00, 165.56,
148.86, 161.07, 166.08. MS-ESI: m/z 423 (M+ + 1). 424; anal. 165.61, 165.80, 167.23, 169.44. MS-ESI: m/z 481 (M+). Anal. calcd
calcd for C25H21N5O2 + H2O: C, 70.91; H, 5.0; N, 16.54%. Found: for C28H25N4O4: C, 69.84; H, 5.23; N, 11.64%. Found: C, 69.85;
C, 70.92; H, 5.03; N, 16.29%.
H, 4.95; N, 11.62%.
(E/Z)-1-Benzyl-3-[(3-hydroxypropylamino)-phenylmethyli-
dene]-1,3-dihydro-2H-pyrido[3,4-b]pyrrolo[3,2-e]pyrazin-2-one
1-Hydroxypropan-3-ammonium (E/Z)-1-(phenylethyl)-3-[(3-
hydroxy-propylamino)-phenylmethylidene]-1,3-dihydro-2H-pyrrolo-
12e. Yellow needles (85 mg, 35%), m.p. 221 1C. E/Z = 2.0 : 1 [2,3-b]quinoxaline-7-carboxylate hydrate 14f. Yellow needles
(CDCl3), E/Z = 2.1 : 1 (DMSO-d6). IR (ATR): 3411, 3241, 3060, (100 mg, 31%), m.p. 107 1C. E/Z = 2.8 : 1 (DMSO-d6). IR (ATR):
1
2937, 2870, 1703, 1612 cmꢂ1
.
1H NMR (300.13 MHz, CDCl3): 3350, 3210, 3031, 2928, 2870, 1672, 1585, 1557 cmꢂ1. H NMR
d = 1.87 (m, 2H, J = 6.0 Hz, Z-CH2), 1.92 (m, 2H, J = 6.0 Hz, (300.13 MHz, DMSO-d6) for 14f + NH2(CH3)2OH: d = 1.73 (m, 6H,
E-CH2; 2H, E/Z-OH), 3.46 (q, 2H, J = 6.0 Hz, Z-CH2-NH), 3.51 J = 6.85 Hz, CH2, E/Z-CH2), 2.87 (t, 4H, J = 7.04 Hz, E/Z-CH2Ph),
c
New J. Chem.
This journal is The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2013